Defining the Role of Adjuvant Chemotherapy After Lobectomy for Typical Bronchopulmonary Carcinoid Tumors
- 1 February 2015
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 99 (2) , 428-434
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Focus on treatment of lung carcinoid tumorOncoTargets and Therapy, 2013
- Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Advanced Lung Neuroendocrine TumorsChest, 2013
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 studyThe Lancet, 2011
- Tracheobronchopulmonary Carcinoid Tumors: Analysis of 40 PatientsAnnals of Thoracic and Cardiovascular Surgery, 2011
- Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II StudyJournal of Clinical Oncology, 2008
- Bronchopulmonary neuroendocrine tumorsCancer, 2008
- Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the LungEuropean Journal of Cardio-Thoracic Surgery, 2007
- Outcome and surgical strategy in bronchial carcinoid tumors: single institution experience with 252 patients☆European Journal of Cardio-Thoracic Surgery, 2007
- Bronchial carcinoid tumors: nodal status and long-term survival after resectionThe Annals of Thoracic Surgery, 2004
- Estimating and Using Propensity Scores with Partially Missing DataJournal of the American Statistical Association, 2000